Trials / Sponsors / Rachel Sanborn
Rachel Sanborn
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer Lung Cancer, Non-small Cell Carcinoma | Phase 2 | 2020-06-18 |